Skip to main content
CSPC Pharmaceutical Group Limited (HKG:1093)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
7.71
+0.09 (1.18%)
Jun 23, 2025, 4:08 PM HKT

CSPC Pharmaceutical Group Revenue

CSPC Pharmaceutical Group had revenue of 7.01B CNY in the quarter ending March 31, 2025, a decrease of -21.91%. This brings the company's revenue in the last twelve months to 27.04B, down -16.49% year-over-year. In the year 2024, CSPC Pharmaceutical Group had annual revenue of 29.01B, down -7.76%.

Revenue (ttm)
27.04B CNY
Revenue Growth
-16.49%
P/S Ratio
3.04
Revenue / Employee
1.26M CNY
Employees
21,400
Market Cap
88.12B HKD

Revenue Chart

* This company reports financials in CNY.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202429.01B-2.44B-7.76%
Dec 31, 202331.45B513.21M1.66%
Dec 31, 202230.94B3.07B11.02%
Dec 31, 202127.87B2.92B11.73%
Dec 31, 202024.94B2.84B12.84%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
BeOne Medicines 32.49B
Hansoh Pharmaceutical Group Company 13.05B
Innovent Biologics 10.03B
JD Health International 61.89B
WuXi Biologics 19.87B
Sino Biopharmaceutical 30.72B
Akeso 2.26B
Sichuan Kelun-Biotech Biopharmaceutical 2.06B
Revenue Rankings

CSPC Pharmaceutical Group News

More News